Corrigendum to “Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy” [Eur J Cancer 75 (April 2017) 109–116](S0959804917300485)(10.1016/j.ejca.2016.12.030);Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy

European Journal of Cancer

Volumn 75, Issue , 2017, Pages 109-116

  Puliti, Donella ^a   Bucchi, Lauro ^l   Mancini, Silvia ^l   Paci, Eugenio ^a   Baracco, Susanna ^m   Campari, Cinzia ^k,n   Canuti, Debora ^o   Cirilli, Claudia ^p   Collina, Natalina ^d   Conti, Giovanni Maria ^q   Di Felice, Enza ^k,n   Falcini, Fabio ^o   Michiara, Maria ^j   Negri, Rossella ^r   Ravaioli, Alessandra ^l   Sassoli de' Bianchi, Priscilla ^s   Serafini, Monica ^o   Zorzi, Manuel ^m   Caldarella, Adele ^a   Cataliotti, Luigi ^t   Zappa, Marco ^a   Manneschi, G ^a   Miccinesi, G ^a   Caranci, N ^f   Naldoni, C ^e   Finarelli, A C ^e   Ferretti, S ^g   Pandolfi, P ^d   Pizzi, L ^d   Petrucci, C ^d   Baldazzi, P ^d   Pasquini, A ^d   Manfredi, M ^d   Saguatti, G ^h   Zatelli, M ⁱ   Sgargi, P ^j   Bozzani, F ^j   Giorgi Rossi, P ^k   Mangone, L ^k   Caroli, S ^k   Vicentini, M ^k   Vattiato, R ^b   Giuliani, O ^b   Balducci, C ^b   Vitali, B ^b   Monticelli, G ^c   more..

^a CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^b Romagna Cancer Institute   (Italy)

^c Romagna Local Health Unit   (Italy)

^d Bologna Health Trust   (Italy)

^e Regional Health Authority   (Italy)

^f Regional Agency for Health and Social Care   (Italy)

^g Local Health Unit   (Italy)

^h BELLARIA HOSPITAL   (Italy)

ⁱ Parma Breast Cancer Screening Programme Centre   (Italy)

^j UNIVERSITY HOSPITAL OF PARMA   (Italy)

^k S MARIA NUOVA HOSPITAL   (Italy)

^l DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^m Occupational Health Unit   (Italy)

ⁿ PATHOLOGY UNIT   (Italy)

^o Local Health Trust   (Italy)

^p Local Health Unit   (Italy)

^q Local Health Unit   (Italy)

^r Local Health Unit   (Italy)

^s Public Health Service Bologna   (Italy)

^t Breast Centres Certification and Senonetwork Italia Onlus   (Italy)

more..

Author keywords

Advanced breast cancer; Cohort study; Mammography screening; Screening attendance; Screening effectiveness; Self selection bias

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; ITALY; MAMMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SOCIAL STATUS; TUMOR INVASION; AGED; BREAST NEOPLASMS; EARLY CANCER DIAGNOSIS; EVALUATION STUDY; INCIDENCE; MASS SCREENING; MIDDLE AGED; PATIENT ATTENDANCE; PATIENT ATTITUDE; PSYCHOLOGY; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

AGED; BREAST NEOPLASMS; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; ITALY; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NO-SHOW PATIENTS; PATIENT ACCEPTANCE OF HEALTH CARE; SOCIOECONOMIC FACTORS;

EID: 85013057066     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2017.08.016     Document Type: Erratum

References (31)

1. [1] Independent UK Panel on Breast Cancer Screening, The benefits and harms of breast cancer screening: an independent review. Lancet 380 (2012), 1778–1786.
2. [2] Lauby-Secretan, B., Scoccianti, C., Loomis, D., Benbrahim-Tallaa, L., Bouvard, V., Bianchini, F., et al., International Agency for Research on Cancer Handbook Working Group. Breast-cancer screening–viewpoint of the IARC Working Group. N Engl J Med 372 (2015), 2353–2358.
3. [3] Autier, P., Héry, C., Haukka, J., Boniol, M., Byrnes, G., Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol 27 (2009), 5919–5923.
4. [4] Autier, P., Boniol, M., Boyle, P., The benefits and harms of breast cancer screening. Lancet, 381, 2013, 800.
5. [5] Welch, H.G., Gorski, D.H., Albertsen, P.C., Trends in metastatic breast and prostate cancer—lessons in cancer dynamics. N Engl J Med 373 (2015), 1685–1687.
6. [6] Puliti, D., Miccinesi, G., Collina, N., De Lisi, V., Federico, M., Ferretti, S., et al., IMPACT Working Group. Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Br J Cancer 99 (2008), 423–427.
7. [7] Foca, F., Mancini, S., Bucchi, L., Puliti, D., Zappa, M., Naldoni, C., et al., IMPACT Working Group. Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy. Cancer 119 (2013), 2022–2028, 10.1002/cncr.28014.
8. [8] Giorgi, D., Giordano, L., Ventura, L., Frigerio, A., Paci, E., Zappa, M., Mammography breast cancer screening in Italy: 2010 survey. Epidemiol Prev 36:6 Suppl 1 (2012), 8–27 Italian.
9. [9] Anttila, A., Lönnberg, S., Ponti, A., Suonio, E., Villain, P., Coebergh, J.W.5, et al. Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registries. Eur J Cancer 51:2 (2015), 241–251.
10. [10] International Union Against Cancer (UICC). Sobin, L., Gospodarowicz, M., Wittekind, C., (eds.) TNM classification of malignant tumours, 7th ed., 2009, Wiley Blackwell, Hoboken, NJ.
11. [11] Caranci, N., Biggeri, A., Grisotto, L., Pacelli, B., Spadea, T., Costa, G., The Italian deprivation index at census block level: definition, description and association with general mortality. Epidemiol Prev 34 (2010), 167–176 Italian.
12. [12] Paci, E., Miccinesi, G., Puliti, D., Baldazzi, P., De Lisi, V., Falcini, F., et al. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res, 8(6), 2006, R68.
13. [13] Crocetti, E., Capocaccia, R., Casella, C., Ferretti, S., Guzzinati, S., Rosso, S., et al. Cancer trends in Italy: figures from cancer registries (1986–1997). Epidemiol Prev 28:2 Suppl (2004), 1–6.
14. [14] Katanoda, K., Qiu, D., Comparison of time trends in female breast cancer incidence (1973–1997) in East Asia, Europe and USA, from cancer incidence in five continents. Vols IV-VIII Jpn J Clin Oncol 37 (2007), 638–639 ù.
15. [15] Soerjomataram, I.1, Pukkala, E., Brenner, H., Coebergh, J.W., On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk. Breast Cancer Res Treat 111:2 (2008), 297–302.
16. [16] Arnold, M., Karim-Kos, H.E., Coebergh, J.W., Byrnes, G., Antilla, A., Ferlay, J., et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory. EJC 51:9 (2015), 1164–1187.
17. [17] Biesheuvel, C., Barratt, A., Howard, K., Houssami, N., Irwig, L., Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 8 (2007), 1129–1138.
18. [18] Puliti, D., Duffy, S.W., Miccinesi, G., de Koning, H., Lynge, E., Zappa, M., et al., EUROSCREEN Working Group. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 19:Suppl 1 (2012), 42–56.
19. [19] Puliti, D., Miccinesi, G., Zappa, M., Manneschi, G., Crocetti, E., Paci, E., Balancing harms and benefits of service mammography screening programs: a cohort study. Breast Cancer Res, 14(1), 2012, R9.
20. [20] Maaskant, A.J., van de Poll-Franse, L.V., Voogd, A.C., Coebergh, J.W., Tutein Nolthenius-Puylaert, M.C., Nieuwenhuijzen, G.A., Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat 113 (2009), 173–179.
21. [21] Maguire, A., Brogi, E., Sentinel lymph nodes for breast carcinoma: a paradigm shift. Arch Pathol Lab Med 140:8 (2016), 791–798.
22. [22] Goodman, S., O'Connor, A., Kandil, D., Khan, A., The ever-changing role of sentinel lymph node biopsy in the management of breast cancer. Arch Pathol Lab Med 138:1 (2014), 57–64.
23. [23] Hofvind, S., Lee, C.I., Elmore, J.G., Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program. Breast Cancer Res Treat 135 (2012), 291–299.
24. [24] Swedish Organised Service Screening Evaluation Group, Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer 109 (2007), 2205–2212.
25. [25] Helvie, M.A., Chang, J.T., Hendrick, R.E., Banerjee, M., Reduction in late-stage breast cancer incidence in the mammography era: implications for overdiagnosis of invasive cancer. Cancer 120:17 (2014), 2649–2656.
26. [26] Fracheboud, J., Otto, S.J., van Dijck, J.A., Broeders, M.J., Verbeek, A.L., de Koning, H.J., National Evaluation Team for Breast cancer screening (NETB). Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 91:5 (2004), 861–867.
27. [27] Autier, P., Boniol, M., The incidence of advanced breast cancer in the West Midlands, United Kingdom. Eur J Cancer Prev 21 (2012), 217–221.
28. [28] Bleyer, A., Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367 (2012), 1998–2005.
29. [29] Nederend, J., Duijm, L.E., Voogd, A.C., Groenewoud, J.H., Jansen, F.H., Louwman, M.W., Trends in incidence and detection of advanced cancer at biennial screening mammography in the Netherlands: a population based study. Breast Cancer Res, 14, 2012, R10.
30. [30] Lousdal, M.L., Kristiansen, I.S., Møller, B., Støvring, H., Effect of organised mammography screening on stage-specific incidence in Norway: population study. Br J Cancer 114:5 (2016), 590–596.
31. [31] Moss, S.M., Nyström, L., Jonsson, H., Paci, E., Lynge, E., Njor, S., et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J Med Screen 19:Suppl 1 (2012), 26–32.